Other

Lessee Operating Lease Liability Payments Due

West Pharmaceutical Services Lessee Operating Lease Liability Payments Due increased by 31.2% to $140.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.4%, from $113.70M to $140.30M. Over 3 years (FY 2020 to FY 2023), Lessee Operating Lease Liability Payments Due shows an upward trend with a 11.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ1 2020
Last reportedQ1 2026

How to read this metric

An increase indicates higher long-term fixed operational costs, while a decrease suggests a reduction in lease commitments.

Detailed definition

This represents the total undiscounted future cash payments required under operating lease agreements. It reflects the f...

Peer comparison

Standardized across all companies reporting under ASC 842, allowing for direct comparison of fixed operational debt-like obligations.

Metric ID: other_lessee_operating_lease_liability_payments_due

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$78.60M$74.10M$86.40M$93.70M$95.20M$104.40M$126.70M$123.20M$119.90M$115.50M$118.10M$115.70M$119.90M$116.40M$113.70M$113.50M$106.90M$140.30M
QoQ Change-5.7%+16.6%+8.4%+1.6%+9.7%+21.4%-2.8%-2.7%-3.7%+2.3%-2.0%+3.6%-2.9%-2.3%-0.2%-5.8%+31.2%
YoY Change+21.1%+40.9%+46.6%+31.5%+25.9%+10.6%-6.8%-6.1%+0.0%+0.8%-1.7%-5.3%-8.2%+23.4%
Range$74.10M$140.30M
CAGR+14.6%
Avg YoY Growth+12.3%
Median YoY Growth+5.7%

Lessee Operating Lease Liability Payments Due at Other Companies

Frequently Asked Questions

What is West Pharmaceutical Services's lessee operating lease liability payments due?
West Pharmaceutical Services (WST) reported lessee operating lease liability payments due of $140.30M in Q1 2026.
How has West Pharmaceutical Services's lessee operating lease liability payments due changed year-over-year?
West Pharmaceutical Services's lessee operating lease liability payments due increased by 23.4% year-over-year, from $113.70M to $140.30M.
What is the long-term trend for West Pharmaceutical Services's lessee operating lease liability payments due?
Over 3 years (2020 to 2023), West Pharmaceutical Services's lessee operating lease liability payments due has grown at a 11.5% compound annual growth rate (CAGR), from $85.20M to $118.10M.
What does lessee operating lease liability payments due mean?
The total amount of future cash payments the company is contractually obligated to pay for operating leases.